Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects With Crohn's Disease

NCT02641392 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT02641392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02641392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Lead sponsor
Celgene
Phase
Phase 3
Overall status
Terminated
Start date
July 25, 2016
Completion date
January 4, 2018
Enrollment
310 (actual)
Sites
231

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease